FIELD: pharmaceutics.
SUBSTANCE: invention relates to chemical-pharmaceutical industry and medicine and describes a method for preparing the composition for parenteral administration, containing (wt%): 2-ethyl-6-methyl-3-hydroxypyridine succinate as an active component – 4.0–6.0; stabilizer – sodium metabisulphite – 0.015–0.045 and water as a solvent – up to 100. Invention can be used in medicine as a drug for treating and preventing various diseases and pathological conditions of a human body.
EFFECT: composition is characterized by stability for three years, low toxicity, comparable with the solution of 2-ethyl-6-methyl-3-hydroxypyridine succinate without stabilizers, allows to implement the therapeutic action of the active substance without undesired secondary pharmacological activity of excipients.
1 cl, 6 ex, 2 tbl
